Skip to main content
. 2020 Jan 23;15(1):e0226681. doi: 10.1371/journal.pone.0226681

Table 3. Splenic and hepatic artery diameter in both groups, in case of the presence or absence of HHT in SAA patients, in case of the presence of absence of SAA in HHT patients.

N Hepatic artery
diameter (mm)±SD
(range)
P Value Splenic artery
diameter(mm)±SD
(range)
P Value
In both groups
    HHT patients 186 8.31±3.38(3.0–24.0) 5.48±1.27(2.8–9.0)
    Control group 186 5.92±1.51(3.0–11.0) < 0.0001 5.45±1.04(3.3–10.5) 0.77
In patients with SAA
    HHT patients 46 9.27±3.45(4.6–20.8) 5.76±1.47(3.5–9.0)
    Control group 10 5.31±0.96(4.4–7.7) < 0.0001 5.75±2.07(4.2–10.5) 0.98
In HHT patients
    With SAA 46 9.27±3.45(4.6–20.8) 5.76±1.47(3.5–9.0)
    Without SAA 140 8.0±3.31(3.0–24.0) 0.03 5.39±1.18(2.8–9.0) 0.08

SAA = splenic artery aneurysm

SD = Standard Deviation

HHT = Hereditary Hemorrhagic Telangiectasia